The Hillman Companies, Inc. Reports Year-to-Date 2020 Financial Results
CINCINNATI, July 20, 2020 (GLOBE NEWSWIRE) — The Hillman Companies, Inc. (NYSE-AMEX: HLM.PR) (the “Company” or “Hillman”) reported today selected […]
Lydall to Report Second Quarter 2020 Results
MANCHESTER, Conn., July 20, 2020 (GLOBE NEWSWIRE) — Lydall, Inc. (NYSE: LDL) announced today that it will release its financial […]
Cohen & Company Announces Successful Launch of €375 Million PriDe III Funds
PHILADELPHIA and New YORK, July 20, 2020 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN) (“Cohen & Company”) […]
Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics
NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, […]
Golden Sky Minerals Completes Phase 1 Exploration Program at Bull’s Eye, Mobilizes to Hotspot
VANCOUVER, British Columbia, July 20, 2020 (GLOBE NEWSWIRE) — Golden Sky Minerals Corp. (AUEN.V) is pleased to announce the completion […]
NexTech AR’s InfernoAR Video Conferencing Virtual Events Software Chosen By ICSOBA
SANTA CRUZ, Calif. and TORONTO, July 20, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: […]
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
China NMPA acceptance of NDA follows recent U.S. FDA approval for the treatment ofadult patients with advanced GIST who have […]
Applied Materials Solves Major Bottleneck to Continued 2D Scaling
SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. today introduced a new technology that removes a […]
ContraFect Announces up to $18.9 Million in Funding from CARB-X to Support Acceleration of the CF-370 Program for Treating Pseudomonas aeruginosa Infections towards Clinical Stage Development
YONKERS, N.Y., July 20, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer
BOSTON, July 20, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing […]
